Successful engraftment of allogeneic peripheral blood stem cell transplant after nonmyeloablative preparative regimen with cytarabine and cyclophosphamide

Report of 2 cases

Nobuharu Fujii, Yoshinobu Maeda, Katsuto Takenaka, Katsuji Shinagawa, Toshi Imai, Teruhiko Kozuka, Kazuma Ikeda, Kazutaka Sunami, Yasushi Hiramatsu, Fumihiko Ishimaru, Kenji Niiya, Mine Harada

Research output: Contribution to journalArticle

Abstract

We report our experience with allogeneic peripheral blood stem cell transplantation (allo-PBSCT) following a nonmyeloablative conditioning regimen consisting of cytarabine (8 g/m2) and cyclophosphamide (120 mg/kg) in the treatment of 2 patients aged 50 and 55 years with refractory chronic myelomonocytic leukemia and chronic myeloid leukemia in accelerated phase, respectively. Our nonmyeloablative regimen was well tolerated by older patients at high risk of regimen-related toxicity by the conventional conditioning regimen but was immunosuppressive enough to achieve mixed chimerism. After allo-PBSCT, we monitored chimerism in these patients by fluorescence in situ hybridization using X- and Y-specific probes and polymerase chain reaction-based analysis of a variable number of tandem repeats. We found that full chimerism and graft versus-leukemia (GVL) effects could be induced in these patients by donor lymphocyte infusions and withdrawal of posttransplantation immunosuppressive therapy. Our observations suggest that a nonmyeloablative conditioning regimen can establish mixed chimerism and that donor lymphocyte infusion may induce GVL effects in older patients at high risk of reg imen-related toxicity.

Original languageEnglish
Pages (from-to)499-503
Number of pages5
JournalInternational Journal of Hematology
Volume72
Issue number4
Publication statusPublished - 2000

Fingerprint

Cytarabine
Chimerism
Cyclophosphamide
Transplants
Peripheral Blood Stem Cell Transplantation
Immunosuppressive Agents
Leukemia, Myeloid, Accelerated Phase
Leukemia
Tissue Donors
Leukemia, Myelomonocytic, Chronic
Lymphocytes
Minisatellite Repeats
Fluorescence In Situ Hybridization
Peripheral Blood Stem Cells
Polymerase Chain Reaction
Therapeutics

Keywords

  • Allogeneic peripheral blood stem cell transplantation
  • Chimerism
  • Donor lymphocyte infusions
  • Graft-versusleukemia effects
  • Nonmyeloablative conditioning regimen

ASJC Scopus subject areas

  • Hematology

Cite this

Successful engraftment of allogeneic peripheral blood stem cell transplant after nonmyeloablative preparative regimen with cytarabine and cyclophosphamide : Report of 2 cases. / Fujii, Nobuharu; Maeda, Yoshinobu; Takenaka, Katsuto; Shinagawa, Katsuji; Imai, Toshi; Kozuka, Teruhiko; Ikeda, Kazuma; Sunami, Kazutaka; Hiramatsu, Yasushi; Ishimaru, Fumihiko; Niiya, Kenji; Harada, Mine.

In: International Journal of Hematology, Vol. 72, No. 4, 2000, p. 499-503.

Research output: Contribution to journalArticle

Fujii, N, Maeda, Y, Takenaka, K, Shinagawa, K, Imai, T, Kozuka, T, Ikeda, K, Sunami, K, Hiramatsu, Y, Ishimaru, F, Niiya, K & Harada, M 2000, 'Successful engraftment of allogeneic peripheral blood stem cell transplant after nonmyeloablative preparative regimen with cytarabine and cyclophosphamide: Report of 2 cases', International Journal of Hematology, vol. 72, no. 4, pp. 499-503.
Fujii, Nobuharu ; Maeda, Yoshinobu ; Takenaka, Katsuto ; Shinagawa, Katsuji ; Imai, Toshi ; Kozuka, Teruhiko ; Ikeda, Kazuma ; Sunami, Kazutaka ; Hiramatsu, Yasushi ; Ishimaru, Fumihiko ; Niiya, Kenji ; Harada, Mine. / Successful engraftment of allogeneic peripheral blood stem cell transplant after nonmyeloablative preparative regimen with cytarabine and cyclophosphamide : Report of 2 cases. In: International Journal of Hematology. 2000 ; Vol. 72, No. 4. pp. 499-503.
@article{52a026cc8b23470fa8a7832499131262,
title = "Successful engraftment of allogeneic peripheral blood stem cell transplant after nonmyeloablative preparative regimen with cytarabine and cyclophosphamide: Report of 2 cases",
abstract = "We report our experience with allogeneic peripheral blood stem cell transplantation (allo-PBSCT) following a nonmyeloablative conditioning regimen consisting of cytarabine (8 g/m2) and cyclophosphamide (120 mg/kg) in the treatment of 2 patients aged 50 and 55 years with refractory chronic myelomonocytic leukemia and chronic myeloid leukemia in accelerated phase, respectively. Our nonmyeloablative regimen was well tolerated by older patients at high risk of regimen-related toxicity by the conventional conditioning regimen but was immunosuppressive enough to achieve mixed chimerism. After allo-PBSCT, we monitored chimerism in these patients by fluorescence in situ hybridization using X- and Y-specific probes and polymerase chain reaction-based analysis of a variable number of tandem repeats. We found that full chimerism and graft versus-leukemia (GVL) effects could be induced in these patients by donor lymphocyte infusions and withdrawal of posttransplantation immunosuppressive therapy. Our observations suggest that a nonmyeloablative conditioning regimen can establish mixed chimerism and that donor lymphocyte infusion may induce GVL effects in older patients at high risk of reg imen-related toxicity.",
keywords = "Allogeneic peripheral blood stem cell transplantation, Chimerism, Donor lymphocyte infusions, Graft-versusleukemia effects, Nonmyeloablative conditioning regimen",
author = "Nobuharu Fujii and Yoshinobu Maeda and Katsuto Takenaka and Katsuji Shinagawa and Toshi Imai and Teruhiko Kozuka and Kazuma Ikeda and Kazutaka Sunami and Yasushi Hiramatsu and Fumihiko Ishimaru and Kenji Niiya and Mine Harada",
year = "2000",
language = "English",
volume = "72",
pages = "499--503",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Successful engraftment of allogeneic peripheral blood stem cell transplant after nonmyeloablative preparative regimen with cytarabine and cyclophosphamide

T2 - Report of 2 cases

AU - Fujii, Nobuharu

AU - Maeda, Yoshinobu

AU - Takenaka, Katsuto

AU - Shinagawa, Katsuji

AU - Imai, Toshi

AU - Kozuka, Teruhiko

AU - Ikeda, Kazuma

AU - Sunami, Kazutaka

AU - Hiramatsu, Yasushi

AU - Ishimaru, Fumihiko

AU - Niiya, Kenji

AU - Harada, Mine

PY - 2000

Y1 - 2000

N2 - We report our experience with allogeneic peripheral blood stem cell transplantation (allo-PBSCT) following a nonmyeloablative conditioning regimen consisting of cytarabine (8 g/m2) and cyclophosphamide (120 mg/kg) in the treatment of 2 patients aged 50 and 55 years with refractory chronic myelomonocytic leukemia and chronic myeloid leukemia in accelerated phase, respectively. Our nonmyeloablative regimen was well tolerated by older patients at high risk of regimen-related toxicity by the conventional conditioning regimen but was immunosuppressive enough to achieve mixed chimerism. After allo-PBSCT, we monitored chimerism in these patients by fluorescence in situ hybridization using X- and Y-specific probes and polymerase chain reaction-based analysis of a variable number of tandem repeats. We found that full chimerism and graft versus-leukemia (GVL) effects could be induced in these patients by donor lymphocyte infusions and withdrawal of posttransplantation immunosuppressive therapy. Our observations suggest that a nonmyeloablative conditioning regimen can establish mixed chimerism and that donor lymphocyte infusion may induce GVL effects in older patients at high risk of reg imen-related toxicity.

AB - We report our experience with allogeneic peripheral blood stem cell transplantation (allo-PBSCT) following a nonmyeloablative conditioning regimen consisting of cytarabine (8 g/m2) and cyclophosphamide (120 mg/kg) in the treatment of 2 patients aged 50 and 55 years with refractory chronic myelomonocytic leukemia and chronic myeloid leukemia in accelerated phase, respectively. Our nonmyeloablative regimen was well tolerated by older patients at high risk of regimen-related toxicity by the conventional conditioning regimen but was immunosuppressive enough to achieve mixed chimerism. After allo-PBSCT, we monitored chimerism in these patients by fluorescence in situ hybridization using X- and Y-specific probes and polymerase chain reaction-based analysis of a variable number of tandem repeats. We found that full chimerism and graft versus-leukemia (GVL) effects could be induced in these patients by donor lymphocyte infusions and withdrawal of posttransplantation immunosuppressive therapy. Our observations suggest that a nonmyeloablative conditioning regimen can establish mixed chimerism and that donor lymphocyte infusion may induce GVL effects in older patients at high risk of reg imen-related toxicity.

KW - Allogeneic peripheral blood stem cell transplantation

KW - Chimerism

KW - Donor lymphocyte infusions

KW - Graft-versusleukemia effects

KW - Nonmyeloablative conditioning regimen

UR - http://www.scopus.com/inward/record.url?scp=0034577455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034577455&partnerID=8YFLogxK

M3 - Article

VL - 72

SP - 499

EP - 503

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 4

ER -